‘Scary but Brilliant’: The Views of People who Use SCRAs in a Community Setting on a Novel Point-of-care SCRA Detection Device

Introduction

Synthetic cannabinoid receptor agonists (SCRAs) are prevalent among people incarcerated in UK prisons and those experiencing homelessness. There are currently no tests that can identify SCRAs at the point-of-care (POC), but a new method for POC SCRA detection in drug materials and human saliva has recently been developed by our team. In this study, we examine the views of people who use SCRAs in community settings on a novel device for SCRA detection, to guide implementation.

Methods

We will interview 12-20 people with lifetime experience of SCRA use who are experiencing homelessness. Interviews will be analyzed using reflexive thematic analysis.

Results

Preliminary results are based on nine interviews conducted in the Southwest of England thus far. Improved detection was believed to act as a deterrent to using SCRAs. There was unanimous agreement that the device should be used in healthcare settings and participants were also positive towards SCRA identification by drug checking services. However, there were mixed responses as to whether they would attend such a community-based service and use the information provided to guide drug-taking. Still, there was a strong wish for more information about SCRAs and the risks of use. Finally, whilst participants were generally positive about prisons using the device to reduce the availability of SCRAs, this was also seen as likely provoking strong negative reactions among users.

Conclusions

Improved POC SCRA detection is viewed positively by users, but potential downstream effects must be evaluated, particularly in forensic settings.